KPP Advisory Services LLC Buys 1,031 Shares of Intuitive Surgical, Inc. $ISRG

KPP Advisory Services LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,088 shares of the medical equipment provider’s stock after purchasing an additional 1,031 shares during the quarter. KPP Advisory Services LLC’s holdings in Intuitive Surgical were worth $1,381,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. Tobam lifted its position in Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in Intuitive Surgical during the 2nd quarter valued at about $27,000. Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $30,000. Riggs Asset Managment Co. Inc. grew its stake in shares of Intuitive Surgical by 84.2% in the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after acquiring an additional 32 shares during the period. Finally, First Command Advisory Services Inc. raised its holdings in shares of Intuitive Surgical by 3,750.0% during the second quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 75 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on ISRG. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, January 21st. Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday. Mizuho set a $575.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Daiwa Capital Markets raised their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Finally, Evercore ISI reduced their price objective on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $620.41.

Intuitive Surgical Price Performance

Shares of ISRG opened at $528.81 on Tuesday. The firm has a market cap of $189.57 billion, a P/E ratio of 67.02, a price-to-earnings-growth ratio of 4.26 and a beta of 1.67. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The company has a 50 day simple moving average of $561.96 and a two-hundred day simple moving average of $511.58.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 earnings per share. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 4,500 shares of the stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the completion of the sale, the vice president directly owned 473 shares in the company, valued at approximately $260,150. The trade was a 81.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 48,152 shares of company stock worth $27,470,571. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.